Physician profile
Connie Marie Brennan
NPI 1447994736
$270,215.19
in general payments reported to CMS, 2019-2025
6 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $7,965 · 2023: $150K · 2024: $51K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $210K · Travel and Lodging: $35K · Consulting Fee: $9,300 · Food and Beverage: $7,506 · Education: $33.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $210,457.65 |
| Travel and Lodging | $34,952.70 |
| Consulting Fee | $9,300.42 |
| Food and Beverage | $7,505.70 |
| Education | $33.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208,500.11 | 2023-2025 | |
| Galderma Laboratories, L.P. | $38,729.11 | 2022-2025 | |
| Revance Therapeutics, INC. | $19,177.34 | 2024-2025 | Daxxify |
| Merz North America, INC. | $3,745.37 | 2023-2024 | Xeomin |
| Allergan, INC. | $44.92 | 2022 | |
| Glaukos Corporation | $18.34 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Brennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.